BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9816040)

  • 1. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.
    Thomssen C; Schmitt M; Goretzki L; Oppelt P; Pache L; Dettmar P; Jänicke F; Graeff H
    Clin Cancer Res; 1995 Jul; 1(7):741-6. PubMed ID: 9816040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.
    Thomssen C; Oppelt P; Jänicke F; Ulm K; Harbeck N; Höfler H; Kuhn W; Graeff H; Schmitt M
    Anticancer Res; 1998; 18(3C):2173-80. PubMed ID: 9703780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer.
    Harbeck N; Alt U; Berger U; Kates R; Krüger A; Thomssen C; Jänicke F; Graeff H; Schmitt M
    Int J Biol Markers; 2000; 15(1):79-83. PubMed ID: 10763146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
    Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
    Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy.
    Harbeck N; Alt U; Berger U; Krüger A; Thomssen C; Jänicke F; Höfler H; Kates RE; Schmitt M
    Clin Cancer Res; 2001 Sep; 7(9):2757-64. PubMed ID: 11555589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cathepsins B and L in primary human breast cancer.
    Foekens JA; Kos J; Peters HA; Krasovec M; Look MP; Cimerman N; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten WL; Klijn JG
    J Clin Oncol; 1998 Mar; 16(3):1013-21. PubMed ID: 9508185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
    Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
    Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
    Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
    Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
    Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
    Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.
    Castiglioni T; Merino MJ; Elsner B; Lah TT; Sloane BF; Emmert-Buck MR
    Hum Pathol; 1994 Sep; 25(9):857-62. PubMed ID: 8088759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive value of cathepsins D and L in operable breast cancer patients.
    Jagodic M; Vrhovec I; Borstnar S; Cufer T
    Neoplasma; 2005; 52(1):1-9. PubMed ID: 15739019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
    Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
    Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
    Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
    Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cathepsins B, H, L and kininogen in breast cancer patients.
    Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna J; Turk V
    Agents Actions Suppl; 1992; 38 ( Pt 2)():350-7. PubMed ID: 1334335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
    Kawasaki G; Kato Y; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsins B, H and L in human breast carcinoma.
    Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna M; Dolenc I; Popovic T; Cotic V; Turk V
    Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):69-74. PubMed ID: 1316176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatins and cathepsins in breast carcinoma.
    Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
    Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
    J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.